Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

5.6%

1 terminated out of 18 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed with results

Key Signals

1 with results86% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (4)
P 2 (1)
P 3 (1)
P 4 (1)

Trial Status

Recruiting7
Completed6
Unknown3
Terminated1
Not Yet Recruiting1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT05255900CompletedPrimary

Effects of Metyrapone in Patients With Hypercortisolism

NCT07412782Not ApplicableRecruiting

REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)

NCT06829537Completed

Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM)

NCT07350031Completed

Serum and Salivary Cortisol Assessment in Patients With Adrenal Incidentalomas and Healthy Controls

NCT06246357Phase 2Recruiting

Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism

NCT07156370RecruitingPrimary

Salivary Cortisol and Hypercortisolism in Type 2 Diabetes

NCT04308590Phase 3CompletedPrimary

A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas

NCT06430528Recruiting

A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement

NCT04127552Recruiting

Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic Alterations

NCT05772169Phase 4CompletedPrimary

Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)

NCT06701838Not Yet Recruiting

Osilodrostat Therapy and 11C-methionine PET to Improve Corticotroph Adenoma Detection

NCT05368090Not ApplicableRecruiting

Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism

NCT06495983Recruiting

Dynamic Hormone Profiling and Multimodal Data Capture in Primary Aldosteronism

NCT02335996Not ApplicableCompletedPrimary

Hypercortisolism and Epicardial Adipose Tissue

NCT05766085UnknownPrimary

Cortisol Secretion, Sensitivity and Activity and Hypertension

NCT04433819Unknown

Nailfold Capillaroscopy Evaluation in Cushing Syndrome Patients

NCT04045015Not ApplicableUnknown

Liquorice and Salivary Cortisol

NCT03379363TerminatedPrimary

Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome

Showing all 18 trials

Research Network

Activity Timeline